ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $317,742 | -55.8% | 28,446 | -15.4% | 0.00% | -100.0% |
| Q2 2023 | $719,511 | -37.5% | 33,622 | +18.1% | 0.00% | 0.0% |
| Q1 2023 | $1,151,529 | -13.1% | 28,475 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,324,425 | -8.0% | 28,470 | +2.5% | 0.00% | -50.0% |
| Q3 2022 | $1,440,000 | +27.3% | 27,768 | +16.1% | 0.00% | +100.0% |
| Q2 2022 | $1,131,000 | -25.7% | 23,915 | +11.8% | 0.00% | 0.0% |
| Q1 2022 | $1,522,000 | -5.7% | 21,384 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $1,614,000 | +27.1% | 21,581 | -3.5% | 0.00% | 0.0% |
| Q3 2021 | $1,270,000 | +22.4% | 22,365 | -5.2% | 0.00% | 0.0% |
| Q2 2021 | $1,038,000 | -15.5% | 23,588 | -5.3% | 0.00% | 0.0% |
| Q1 2021 | $1,228,000 | -23.0% | 24,907 | -34.2% | 0.00% | 0.0% |
| Q4 2020 | $1,594,000 | -0.4% | 37,837 | +8.3% | 0.00% | 0.0% |
| Q3 2020 | $1,601,000 | -7.7% | 34,945 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $1,735,000 | +136.4% | 34,559 | +142.5% | 0.00% | 0.0% |
| Q1 2020 | $734,000 | -45.6% | 14,252 | -34.7% | 0.00% | 0.0% |
| Q4 2019 | $1,349,000 | +14.0% | 21,832 | +10.9% | 0.00% | 0.0% |
| Q3 2019 | $1,183,000 | -37.9% | 19,694 | -12.7% | 0.00% | -50.0% |
| Q2 2019 | $1,905,000 | -6.9% | 22,567 | +5.3% | 0.00% | 0.0% |
| Q1 2019 | $2,047,000 | +5.1% | 21,435 | -22.1% | 0.00% | 0.0% |
| Q4 2018 | $1,947,000 | -28.5% | 27,500 | -13.8% | 0.00% | 0.0% |
| Q3 2018 | $2,724,000 | -23.3% | 31,887 | +4.1% | 0.00% | -33.3% |
| Q2 2018 | $3,552,000 | +52.4% | 30,643 | +6.4% | 0.00% | +50.0% |
| Q1 2018 | $2,330,000 | +39.0% | 28,794 | +0.8% | 0.00% | +100.0% |
| Q4 2017 | $1,676,000 | +11.9% | 28,578 | -10.7% | 0.00% | 0.0% |
| Q3 2017 | $1,498,000 | +45.3% | 31,994 | +11.7% | 0.00% | 0.0% |
| Q2 2017 | $1,031,000 | -28.0% | 28,651 | -38.3% | 0.00% | 0.0% |
| Q1 2017 | $1,431,000 | +22.3% | 46,458 | +33.0% | 0.00% | 0.0% |
| Q4 2016 | $1,170,000 | +57.3% | 34,942 | +25.1% | 0.00% | 0.0% |
| Q3 2016 | $744,000 | +22.6% | 27,927 | +1.3% | 0.00% | 0.0% |
| Q2 2016 | $607,000 | -39.0% | 27,565 | -18.7% | 0.00% | 0.0% |
| Q1 2016 | $995,000 | +78.3% | 33,887 | +100.3% | 0.00% | 0.0% |
| Q4 2015 | $558,000 | -4.0% | 16,916 | +5.0% | 0.00% | 0.0% |
| Q3 2015 | $581,000 | -71.4% | 16,110 | -64.3% | 0.00% | -50.0% |
| Q2 2015 | $2,029,000 | +118.4% | 45,110 | +48.5% | 0.00% | +100.0% |
| Q1 2015 | $929,000 | -1.9% | 30,378 | +63.2% | 0.00% | 0.0% |
| Q4 2014 | $947,000 | +25.4% | 18,613 | -2.5% | 0.00% | 0.0% |
| Q3 2014 | $755,000 | -5.9% | 19,088 | +2.6% | 0.00% | 0.0% |
| Q2 2014 | $802,000 | +89.2% | 18,605 | +75.6% | 0.00% | – |
| Q1 2014 | $424,000 | +60.6% | 10,598 | +9.7% | 0.00% | – |
| Q4 2013 | $264,000 | – | 9,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |